CompletedPhase 2NCT04351126

Management of Ovarian Hyperstimulation Syndrome as a State of Defective Mineralocorticoid Response

Studying Ovarian hyperstimulation syndrome

Last synced from ClinicalTrials.gov May 4, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Ganin Fertility Center
Principal Investigator: Muhammad S Zeafan, MBBCH
Ganin Fertility Center
Intervention: Fludrocortisone 0.1 Milligrams (mg)(drug)
Enrollment: 107 enrolled
Eligibility: 18-40 years · FEMALE
Timeline: 2019 – 2020

Study locations (1)

Ganin Fertility Center, Cairo, Maadi, Egypt

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04351126 on ClinicalTrials.gov

Other trials for Ovarian hyperstimulation syndrome

Additional recruiting or active studies for the same condition.

RECRUITINGPHASE2NCT07043322
Clinical Study to Evaluate Efficacy of Cabergoline to Coasting in Reducing the Incidence of Ovarian Hyperstimulation Syndrome
Tanta University

See all trials for Ovarian hyperstimulation syndrome →

← Back to all trials